Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer | |
Mu, GG; Zhang, LL; Li, HY; Liao, Y; Yu, HG | |
刊名 | DIGESTIVE DISEASES AND SCIENCES |
2015-04 | |
卷号 | 60期号:4页码:1067-1080 |
关键词 | Notch1 PTEN Pancreatic cancer Thymoquinone Chemoresistance Apoptosis |
ISSN号 | 0163-2116 |
通讯作者 | Yu, HG (reprint author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Hubei Province, Peoples R China. |
学科主题 | Gastroenterology & Hepatology |
收录类别 | SCIE ; PUBMED ; MEDLINE |
出版地 | DORDRECHT |
语种 | 英语 |
WOS记录号 | WOS:000354464900041 |
内容类型 | 期刊论文 |
源URL | [http://ir.lzu.edu.cn/handle/262010/179351] |
专题 | 第二临床医学院_期刊论文 |
推荐引用方式 GB/T 7714 | Mu, GG,Zhang, LL,Li, HY,et al. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer[J]. DIGESTIVE DISEASES AND SCIENCES,2015,60(4):1067-1080. |
APA | Mu, GG,Zhang, LL,Li, HY,Liao, Y,&Yu, HG.(2015).Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.DIGESTIVE DISEASES AND SCIENCES,60(4),1067-1080. |
MLA | Mu, GG,et al."Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer".DIGESTIVE DISEASES AND SCIENCES 60.4(2015):1067-1080. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论